NORS^TM – Introducing a new patented platform technology – a first-line non-antibiotic antimicrobial to help fight drug resistant infections and pandemics

SaNOtize Research and Development Corp., is a rapidly growing pharmaceutical company focused on developing and commercializing high quality, innovative products.

We aim to improve the quality of life for people throughout the world by using our proprietary biotechnology platform to remedy topical infections that negatively impact quality of life. Therapeutic targets include SARS-COV-2 (COVID-19), influenza, onychomycosis (nail fungus), chronic sinusitis, diabetic foot ulcers and others.

Our Team

Dr. Gilly Regev, PhD and Dr. Chris Miller, PhD, BA, RT are co-founders of SaNOtize. Dr. Regev and Dr. Miller are among a small group of people who are experts at using nitric oxide therapeutically. The SaNOtize leadership team is complemented by a number of talented researchers, scientists and accomplished entrepreneurs, and is advised by a distinguished board of directors.

The Latest News

Read our latest Press Releases

Learn about current initiatives and updates from saNOtize.

logged in